Klacid (Clarithromycin)

Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking the translocation step of peptide elongation. This action stops bacterial growth and leads to the elimination of susceptible microorganisms.

The dosage of Klacid is individualized by the prescribing healthcare professional based on the infection being treated, patient age, weight, renal and hepatic function, and local resistance patterns. Patients should follow the prescriber’s instructions and the product label.

Safety data for clarithromycin in pregnancy are limited, and it should only be used if the potential benefit justifies any potential risk to the fetus. Clarithromycin is excreted in breast milk; breastfeeding mothers should discuss risks and benefits with their healthcare provider.

To order Klacid, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Klacid (clarithromycin) offers a broader spectrum against certain Gram‑positive and atypical organisms compared with older macrolides like erythromycin. It also has a more convenient dosing schedule and better gastric stability, but it shares class‑related drug‑interaction risks, especially with CYP3A4 substrates.

Klacid should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Klacid is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce gastrointestinal upset. The exact administration schedule is determined by the prescriber.

Serious risks include Clostridioides difficile‑associated diarrhea, hepatotoxicity indicated by elevated liver enzymes, QT interval prolongation leading to arrhythmias, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like persistent diarrhea, jaundice, palpitations, or rash.

Klacid should not be used by individuals with a known hypersensitivity to clarithromycin, other macrolides, or any component of the formulation. It is also contraindicated in patients taking certain medications that have major interactions, such as strong CYP3A4 inhibitors, ciclosporin, simvastatin, or pimozide.